CEO Dr Bianco shares TuHURA's work with the #FDA's Oncology Center of Excellence to construct a trial to satisfy requirements for accelerated & full approval of IFx-2.0 in Merkel Cell Carcinoma
$HURA
#TuhuraBio #Bioscience #LifeSciences #Oncology #TargetedTherapies
youtube.com/shorts/eeS09...